Cited by 108Prostate Cancer Treatment and ResearchHormonal and reproductive studiesAdrenal Hormones and Disorders

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.

BÉLANGER, ALAIN, BROCHU, MICHÈLE, CLICHE, JACQUES·1986·The Journal of Clinical Endocrinology & Metabolism

Open this paper in CoChat — free account

Abstract

The levels of plasma dehydroepiandrosterone (DHEA), androst-5-ene-3 beta,17 beta-diol (delta 5-diol), testosterone (T), dihydrostestosterone (DHT), androstane-3 alpha,17 beta-diol (3 alpha-diol), androsterone (ADT), and the related glucuronide (G) derivatives were determined in intact and castrated men with prostatic cancer. The plasma concentrations of DHEA and DHEA-G were not significantly different in intact and castrated men while delta 5-diol as well as delta 5-diol-G were 50% lowered in castrated men. As expected, T and DHT concentrations were markedly lower in castrated men. These low plasma levels of T and DHT were accompanied by a decrease of 3 alpha-diol, ADT, T-G, 3 alpha-diol-G, and ADT-G levels. There was, in unoperated men, a positive correlation between the levels of DHEA and ADT-G as well as DHEA and DHEA-G, while T values were highly correlated with ADT-G and 3 alpha-diol-G levels. Furthermore, a significant relationship was found between DHEA and ADT-G as well as 3 alpha-diol-G in castrated men. Our data clearly demonstrate that ADT-G and 3 alpha-diol-G levels are more affected by castration than are the corresponding unconjugated steroids and suggest that these steroid glucuronides should be good markers of androgen metabolism. Moreover, the significant relationship between DHEA, ADT-G, and 3 alpha-diol-G in castrated men also suggests that approximately 30% of C-19 steroids from the adrenals are converted to T and DHT, which are further transformed into steroid glucuronides.

Integrity signals

Registry

Crossref · 10.1210/jcem-62-5-812

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Extension of Multiple Range Tests to Group Means with Unequal Numbers of Replications
Kramer, C. Y. (1956) · Biometrics · doi:10.2307/3001469 · Cited by 3,146
COMPUTER ANALYSIS OF RADIOLIGAND ASSAY AND RADIOIMMUNOASSAY DATA
Rodbard, D., & Lewald, J. E. (1970) · European Journal of Endocrinology · doi:10.1530/acta.0.065s079 · Cited by 608
The pathogenesis of benign prostatic hyperplasia
Wilson, J. D. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90267-3 · Cited by 352
STEROIDS OF ADRENAL ORIGIN METABOLIZED BY HUMAN PROSTATIC TISSUE BOTH IN VIVO AND IN VITRO
Harper, M. E., Pike, A. W., Peeling, W. B., & Griffiths, K. (1974) · Journal of Endocrinology · doi:10.1677/joe.0.0600117 · Cited by 190
Simultaneous radioimmunoassay of progestins, androgens and estrogens in rat testis
Bèlanger, A., Caron, S., & Picard, V. (1980) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(80)90190-9 · Cited by 177
Increased 5α-reductase activity in idiopathic hirsutism
Serafini, P. C., & Løbo, R. A. (1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48320-2 · Cited by 135
Studies on testosterone metabolism in subjects with testicular feminization syndrome
MAUVAIS-JARVIS, P., Bercovici, J. P., Crépy, O., & Gauthier, F. (1970) · Journal of Clinical Investigation · doi:10.1172/jci106219 · Cited by 111
Studies on the Origin of Androstanediol and Androstanediol Glucuronide in Young and Elderly Men*
Morimoto, I., Edmiston, A., HAWKS, D., & Horton, R. (1981) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-52-4-772 · Cited by 108
Simultaneous Determination of Urinary Androstanediol and Testosterone as an Evaluation of Human Androgenicity
MAUVAIS-JARVIS, P., Charransol, G., & Masson, F. (1973) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-36-3-452 · Cited by 106
Origin of Plasma Androstanediol Glucuronide in Men*
Moghissi, E. S., Ablan, F., & Horton, R. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-417 · Cited by 102

Show all 20 references

Sorted by citations

Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Is dehydroepiandrosterone a hormone?
Labrie, F., Luu-The, V., Bèlanger, A., Lin, S.-X., Simard, J., Pelletier, G., & Labrie, C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06264 · Cited by 460
Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Bèlanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.-L., & Labrie, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962278 · Cited by 437
DHEA and its transformation into androgens and estrogens in peripheral target tissues: Intracrinology
Labrie, F., Luu-The, V., Labrie, C., & Simard, J. (2001) · Frontiers in Neuroendocrinology · doi:10.1006/frne.2001.0216 · Cited by 366
Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Self-citation
DHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280
Self-citation
Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans
Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., & Chouinard, S. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.10.005 · Cited by 235
Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men.
Bélanger, B., Bélanger, A., Labrie, F., Dupont, A., Cusan, L., & Monfette, G. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90514-1 · Cited by 212
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.
Wu, A. H., Whittemore, A. S., Kolonel, L. N., John, E. M., Gallagher, R. P., West, D. W., Hankin, J. H., Teh, C., Dreon, D. M., & Paffenbarger, R. S. (1995) · PubMed · Cited by 201
Androgen receptor gene and hormonal therapy failure of prostate cancer.
Koivisto, P. A., Kolmer, M., Visakorpi, T., & Kallioniemi, O. (1998) · Europe PMC (PubMed Central) · Cited by 195
Isolation and Characterization of a Novel cDNA Encoding a Human UDP-Glucuronosyltransferase Active on C19 Steroids
Beaulieu, M., Lávesque, E., Hum, D. W., & Bálanger, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22855 · Cited by 187
Clinical and Biochemical Parameters of Androgen Action in Normal Healthy CaucasianVersusChinese Subjects
Lookingbill, D. P., DEMERS, L. M., Wang, C. E., LEUNG, A., Rittmaster, R. S., & Santen, R. J. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-6-1242 · Cited by 179
The Adrenal Androgen Androstenediol Is Present in Prostate Cancer Tissue after Androgen Deprivation Therapy and Activates Mutated Androgen Receptor
Mizokami, A., Koh, E., Fujita, H., Maeda, Y., Egawa, M., Koshida, K., Honma, S., Keller, E. T., & Namiki, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-0130 · Cited by 175
Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.
LABRIE, C., BELANGER, A., & LABRIE, F. (1988) · Endocrinology · doi:10.1210/endo-123-3-1412 · Cited by 167
Mechanism of action and pure antiandrogenic properties of flutamide
Labrie, F. (1993) · Cancer · doi:10.1002/1097-0142(19931215)72:12+ · Cited by 140
Influence of diet on plasma steroid and sex plasma binding globulin levels in adult men
BÉLANGER, A., Locong, A. H., Noël, C., Cusan, L., Dupont, A., Prévost, J., Caron, S., & Sévigny, J. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90459-7 · Cited by 137
Isolation and Characterization of the UGT2B28 cDNA Encoding a Novel Human Steroid Conjugating UDP-Glucuronosyltransferase
Lévesque, É., Turgeon, D. K., Carrier, J.-S., Montminy, V., Beaulieu, M., & Bélanger, A. (2001) · Biochemistry · doi:10.1021/bi002607y · Cited by 136
Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues
Bélanger, A., Hum, D. W., Beaulieu, M., Lévesque, É., Guillemette, C., Tchernof, A., Bélanger, G., Turgeon, D., & Dubois, S. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00183-0 · Cited by 131
Intracrinology and The Skin
Labrie, F., Luu-The, V., Labrie, C., Pelletier, G., & El-Alfy, M. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053264 · Cited by 128
Panhypopituitarism as a Model to Study the Metabolism of Dehydroepiandrosterone (DHEA) in Humans
Young, J., Couzinet, B., NAHOUL, K., Brailly, S., Chanson, P., Baulieu, E. E., & SCHAISON, G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4157 · Cited by 133
Combination therapy for prostate cancer. Endocrine and biologic basis of its choice as new standard first-line therapy
Labrie, F., Bélanger, A., Simard, J., Labrie, C., & Dupont, A. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3+ · Cited by 93
Differential Regulation of Two Uridine Diphospho-Glucuronosyltransferases, UGT2B15 and UGT2B17, in Human Prostate LNCaP Cells1
Guillemette, C., Lévesque, É., Beaulieu, M., Turgeon, D. K., Hum, D. W., & Bélanger, A. (1997) · Endocrinology · doi:10.1210/endo.138.7.5226 · Cited by 91
Inactivation by UDP-glucuronosyltransferase enzymes: The end of androgen signaling
Chouinard, S., Yueh, M.-F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., Barbier, O., & Bélanger, A. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.03.016 · Cited by 90
Self-citation
Increased UDP-glucuronosyltransferase activity and decreased prostate specific antigen production by biochanin A in prostate cancer cells.
Sun, X., Plouzek, C. A., Henry, J. P., Wang, T. T. Y., & Phang, J. M. (1998) · PubMed · Cited by 88
Stimulation of androgen-dependent gene expression by the adrenal precursors dehydroepiandrosterone and androstenedione in the rat ventral prostate.
LABRIE, C., SIMARD, J., ZHAO, H. F., BELANGER, A., PELLETIER, G., & LABRIE, F. (1989) · Endocrinology · doi:10.1210/endo-124-6-2745 · Cited by 80
New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists
Shore, N. D., Abrahamsson, P.-A., Anderson, J., Crawford, E. D., & Lange, P. (2012) · Prostate Cancer and Prostatic Diseases · doi:10.1038/pcan.2012.25 · Cited by 80
Sex steroids in Sjögren’s syndrome
Konttinen, Y. T., Fuellen, G., Bing, Y., Porola, P., Stegaev, V., Trokovic, N., Falk, S. S. I., Liu, Y., Szodoray, P., & Takakubo, Y. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.01.004 · Cited by 78
Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men
Vandenput, L., Labrie, F., Mellström, D., Swanson, C., Knutsson, T., Peeker, R., Ljunggren, Ö., Orwoll, E., Eriksson, A. L., Damber, J.-E., et al. (2007) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.061018 · Cited by 71
Testosterone and prostate specific antigen stimulate generation of reactive oxygen species in prostate cancer cells
Sun, X., Donald, S. P., & Phang, J. M. (2001) · Carcinogenesis · doi:10.1093/carcin/22.11.1775 · Cited by 71
HOW IS ANDROGEN-DEPENDENT METASTATIC PROSTATE CANCER BEST TREATED?
Robson, M., & Dawson, N. A. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70364-6 · Cited by 70
Endocrine Therapy for Prostate Cancer
Labrie, F. (1991) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30247-0 · Cited by 65
Cyclin G‐associated kinase: A novel androgen receptor‐interacting transcriptional coactivator that is overexpressed in hormone refractory prostate cancer
Ray, M. R., Wafa, L. A., Cheng, H., Snoek, R., Fazli, L., Gleave, M. E., & Rennie, P. S. (2005) · International Journal of Cancer · doi:10.1002/ijc.21469 · Cited by 61
Androgen Conjugates: Physiology and Clinical Significance
Rittmaster, R. S. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-1-121 · Cited by 56
Effect of Interleukins on UGT2B15 and UGT2B17 Steroid Uridine Diphosphate-Glucuronosyltransferase Expression and Activity in the LNCaP Cell Line
Lévesque, É., Beaulieu, M., Guillemette, C., Hum, D. W., & Bélanger, A. (1998) · Endocrinology · doi:10.1210/endo.139.5.6001 · Cited by 58
Structural Characterization and Expression of the Human Dehydroepiandrosterone Sulfotransferase Gene
LUU-THE, V., Dufort, I., Paquet, N., Reimnitz, G., & Labrie, F. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.511 · Cited by 53
Orchidectomy or oestrogen treatment in prostatic cancer: effects on serum levels of adrenal androgens and related steroids
Stege, R., ERIKSSON, A., Henriksson, P., & Carlström, K. (1987) · International Journal of Andrology · doi:10.1111/j.1365-2605.1987.tb00357.x · Cited by 52
Plasma levels of C-19 steroids and 5α-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women
Brochu, M., Bélanger, A., & Tremblay, R. R. (1987) · Fertility and Sterility · doi:10.1016/s0015-0282(16)59589-2 · Cited by 52
Correlation of Serum 3α-Androstanediol Glucuronide with Acne and Chest Hair Density in Men
Lookingbill, D. P., Egan, N., Santen, R. J., & DEMERS, L. M. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-5-986 · Cited by 51
Expression of the androgen metabolizing enzyme UGT2B15 in adipose tissue and relative expression measurement using a competitive RT-PCR method
Tchernof, A., Lévesque, É., Beaulieu, M., Couture, P., Després, J., Hum, D. W., & Bélanger, A. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00709.x · Cited by 50
Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency
Rösler, A., Bèlanger, A., & Labrie, F. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.3.1325474 · Cited by 48
Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis
Kumagai, J., Hofland, J., Erkens‐Schulze, S., Dits, N. F. J., Steenbergen, J., Jenster, G. W., Homma, Y., de Jong, F. H., & van Weerden, W. M. (2013) · The Prostate · doi:10.1002/pros.22655 · Cited by 46
Levels of plasma C19 steroids and 5 alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals
Guillemette, C., Hum, D. W., & Bèlanger, A. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.2.e348 · Cited by 45
Levels of eighteen non-conjugated and conjugated steroids in human breast cyst fluid: Relationships with cyst type
BÉLANGER, A., Caron, S., Labrie, F., Naldoni, C., Dogliotti, L., & Angeli, A. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90222-f · Cited by 44
Preclinical models of prostate cancer — modelling androgen dependency and castration resistance in vitro, ex vivo and in vivo
Germain, L., Lafront, C., Paquette, V., Neveu, B., Paquette, J., Pouliot, F., & Audet‐Walsh, É. (2023) · Nature Reviews Urology · doi:10.1038/s41585-023-00726-1 · Cited by 47
Production and secretion of C-19 steroids by rat and guinea pig adrenals
Bélanger, B., Couture, J., Caron, S., Bodou, P., Fiet, J., & BÉLANGER, A. (1990) · Steroids · doi:10.1016/0039-128x(90)90060-o · Cited by 42
Free Fatty Acids Increase Androgen Precursorsin Vivo
Mai, K., Bobbert, T., Kullmann, V., Andres, J., Rochlitz, H. J., Osterhoff, M. A., Weickert, M. O., Bähr, V., Möhlig, M., Pfeiffer, A. F. H., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2069 · Cited by 41
Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate
Brochu, M., Bélanger, A., Dupont, A., Cusan, L., & Labrie, F. (1987) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(87)90388-8 · Cited by 41
Dehydroepiandrosterone, androgens and the mammary gland
Labrie, F. (2006) · Gynecological Endocrinology · doi:10.1080/09513590600624440 · Cited by 39
A physiological dose of estradiol with progesterone affects striatum biogenic amines
Morissette, M., Lévesque, D., Bélanger, A., & Paolo, T. D. (1990) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y90-231 · Cited by 39
Suppression of Δ 5 -androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells
Chang, H., Miyamoto, H., Marwah, P., Lardy, H. A., Yeh, S., Huang, K., & Chang, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11173 · Cited by 39
Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.
Wu, A. H., Whittemore, A. S., Kolonel, L. N., Stanczyk, F. Z., John, E. M., Gallagher, R. P., & West, D. W. (2001) · PubMed · Cited by 38
Androstane-3α,17β-Diol Glucuronide as a Steroid Correlate of Visceral Obesity in Men*
Tchernof, A., Labrie, F., Bélanger, A., Prud’homme, D., Bouchard, C., Tremblay, A., Nadeau, A., & Després, J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3924 · Cited by 38
Sex steroid metabolism in the regulation of bone health in men
Vandenput, L., & Ohlsson, C. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2010.03.067 · Cited by 37
DHEA and the Skeleton (Through the Ages)
Gordon, C. M., Glowacki, J., & LeBoff, M. S. (1999) · Endocrine · doi:10.1385/endo:11:1:1 · Cited by 37
ANDROSTERONE GLUCURONIDE IS A MARKER OF ADRENAL HYPERANDROGENISM IN HIRSUTE WOMEN
Thompson, D. L., Horton, N., & Rittmaster, R. S. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00868.x · Cited by 37
Biosynthesis and Degradation of Androgens in Human Prostatic Cancer Cell Lines
Lacoste, D., Bélanger, A., & Labrie, F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb34313.x · Cited by 35
Increase in Plasma Steroid Glucuronide Levels in Men from Infancy to Adulthood
Brochu, M., & Bélanger, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-6-1283 · Cited by 35
Variant allele of HSD3B1 increases progression to castration‐resistant prostate cancer
Wu, G., Huang, S., Nastiuk, K. L., Li, J., Gu, J., Wu, M., Zhang, Q., Lin, H., & Wu, D. (2015) · The Prostate · doi:10.1002/pros.22967 · Cited by 32
Androstanediol Glucuronide Isomers in Normal Men and Women and in Men Infused with Labeled Dihydrotestosterone*
Rittmaster, R. S., THOMPSON, D. L., LISTWAK, S. J., & Loriaux, D. L. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-212 · Cited by 32
Expression and Characterization of a Novel UDP-Glucuronosyltransferase, UGT2B9, from Cynomolgus Monkey
Bélanger, G., BEAULIEU, M., Lévesque, É., Hum, D. W., & Bélanger, A. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.1195 · Cited by 32
Comparative study of plasma steroid and steroid glucuronide levels in normal men and in men with benign prostatic hyperplasia
Brochu, M., & Bélanger, A. (1987) · The Prostate · doi:10.1002/pros.2990110105 · Cited by 31
Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
Zang, T., Tamae, D., Mesaros, C., Wang, Q., Huang, M., Blair, I. A., & Penning, T. M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.08.001 · Cited by 29
Stronger Suppression of Serum Testosterone and FSH Levels by a Synthetic Estrogen than by Castration or an LH-RH Agonist.
Kitahara, S., Yoshida, K., Ishizaka, K., Kageyama, Y., Kawakami, S., Tsujii, T., & Oshima, H. (1997) · Endocrine Journal · doi:10.1507/endocrj.44.527 · Cited by 27
Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in previously untreated patients with clinical stage D2 prostate cancer: Today's therapy of choice
Labrie, F., Dupont, A., Cusan, L., Giguère, M., Beroeron, N., Borsanyi, J.-P., Lacourcière, Y., Bélanger, A., Emond, J., Monfette, G., et al. (1988) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(88)90083-0 · Cited by 25
Relationship between serum testosterone and sex hormone‐binding globulin in adult men with intact or absent gonadal function
Carlström, K., ERIKSSON, A., Stege, R., & Rannevik, G. (1990) · International Journal of Andrology · doi:10.1111/j.1365-2605.1990.tb00961.x · Cited by 23
Unconjugated and Glucuronide Steroid Levels in Human Breast Cyst Fluid
Bèlanger, A., Labrie, F., & Angeli, A. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb17795.x · Cited by 22
Effects of adrenocorticotropin on adrenal and plasma 11β-hydroxyandrostenedione in the guinea pig and determination of its relative androgen potency
Bélanger, B., Fiet, J., & Bé'elanger, A. (1993) · Steroids · doi:10.1016/0039-128x(93)90014-e · Cited by 20
The effect of flutamide on basal and ACTH-stimulated plasma levels of adrenal androgens in patients with advanced prostate cancer
Balzano, S., Cappa, M., Migliari, R., Scarpa, R. M., Danielli, E., Campus, G., Pintus, C., Sica, V., Usai, E., & Martino, E. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350920 · Cited by 20
Does prolonged combined androgen blockade have survival benefits over short-term combined androgen blockade therapy?
Sarosdy, M. F., Schellhammer, P. F., Johnson, R. T., Carroll, K., & Kolvenbag, G. J. C. M. (2000) · Urology · doi:10.1016/s0090-4295(99)00574-9 · Cited by 19
Combination therapy with flutamide and medical (LHRH agonist) or surgical castration in advanced prostate cancer: 7-year clinical experience
Labrie, F., Dupont, A., Cusan, L., Gomez, J., Emond, J., & Monfette, G. (1990) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(90)90448-t · Cited by 18
DHEA as physiological replacement therapy at menopause
Labrie, F. (1998) · Journal of Endocrinological Investigation · doi:10.1007/bf03350777 · Cited by 17
A Comprehensive Analysis of Steroid Hormones and Progression of Localized High-Risk Prostate Cancer
Lévesque, É., Caron, P., Lacombe, L., Turcotte, V., Simonyan, D., Fradet, Y., Aprikian, A. G., Fred Saad, C., Carmel, M., Chevalier, S., et al. (2019) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-1002 · Cited by 16
Conjugated and unconjugated C-21, C-19 and C-18 steroid concentrations in human follicular fluid from hyperstimulated follicles
Prévost, J., Brochu, M., Bèlanger, A., & Lambert, R. D. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082705 · Cited by 16
3β-Acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity
Miyamoto, H., Marwah, P., Marwah, A. K., Lardy, H. A., & Chang, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0831001100 · Cited by 16
Phase Two Steroid Metabolism and Its Roles in Breast and Prostate Cancer Patients
McNamara, K. M., Nakamura, Y., Miki, Y., & Sasano, H. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00116 · Cited by 14
DHEA: A biologic conundrum
Herrington, D. M. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90176-7 · Cited by 14
Adrenal precursor C19 steroids are potent stimulators of growth of androgen-sensitive mouse mammary carcinoma Shionogi cells in vitro
Bégin, D., Lüthy, I. A., & Labrie, F. (1988) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(88)90157-8 · Cited by 14
Combination therapy with castration and flutamide: Today's treatment of choice for prostate cancer
Labrie, F., Dupont, A., Cusan, L., Manhès, G., Bergeron, N., Lacourcière, Y., Pineault, S., Bélanger, A., Monfette, G., & Emond, J. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90499-8 · Cited by 13
Identification of steroid derivatives that function as potent antiandrogens
Miyamoto, H., Marwah, P., Marwah, A. K., Yang, Z., Chung, C., Altuwaijri, S., Chang, C., & Lardy, H. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21217 · Cited by 12
Local effect of the rabbit embryo-foetus on uterine progesterone and pregnenolone levels
Dugré, F. J., Lambert, R. D., Bèlanger, A., Fortier, M. A., & Caron, S. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90152-4 · Cited by 12
Will the experience with tamoxifen in breast cancer help define the role of antiandrogens in prostate cancer?
Chodak, G. W., & Kolvenbag, G. J. C. M. (2001) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500518 · Cited by 12
Adrenal steroid precursors exert potent androgenic action in the hamster sebaceous glands of flank organs and ears
Chen, C., Bèlanger, A., & Labrie, F. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612511 · Cited by 11
The Androgen-Conjugating Uridine Diphosphoglucuronosyltransferase-2B Enzymes Are Differentially Expressed Temporally and Spatially in the Monkey Follicle throughout the Menstrual Cycle
Barbier, O., Girard, C., Berger, L., Alfy, M. E., Bélanger, A., & Hum, D. W. (2001) · Endocrinology · doi:10.1210/endo.142.6.8040 · Cited by 10
Steroidogenesis in guinea pig adrenal cortex: Effects of ACTH on steroid secretion and steroidogenic enzyme activities and expression
Provencher, P. H., Tremblay, Y., Bélanger, B., & Bèlanger, A. (1992) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(92)90312-7 · Cited by 9
A multivariate approach to the description of patient populations. An example of the analysis of the hormone profiles of patients with advanced prostate cancer
Ojasoo, T., Fiet, J., Raynaud, J., & Doré, J. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90293-6 · Cited by 8
Effects of 4-MA, a potent inhibitor of 5α-reductase, on 3β-hydroxysteroid dehydrogenase/Δ5−Δ4-isomerase activity in guinea pig adrenals
Perron, S., & Bèlanger, A. (1994) · Steroids · doi:10.1016/0039-128x(94)90004-3 · Cited by 7
Endocrine and adrenergic pharmacological intervention in diseasesof the prostate
Rane, A. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00688.x · Cited by 7
Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA
Martel, C., Trudel, C., Couët, J., Labrie, C., Bélanger, A., & Labrie, F. (1993) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(93)90253-g · Cited by 7
Prostate Cancer and Combined Androgen Blockade at All Stages of Disease
Labrie, F. (2000) · Springer eBooks · doi:10.1007/978-2-8178-0920-5_12 · Cited by 7
Neurobiology and Hormonal Control of Lacrimal and Salivary Gland Function
Konttinen, Y. T., Porcar, A. V., Porola, P., Koskenpato, K., Lorés, M., Pöllänen, R., Stegaev, V., Virkki, L., Spaan, M., & PRZYBYLA, B. D. (2011) · Springer eBooks · doi:10.1007/978-1-60327-957-4_11 · Cited by 6
Influences of Gonadal and Adrenal Androgens on the Side Glands of Suncus Murinus.
Sonoda, T., Itami, S., Kurata, S., & Takayasu, S. (1991) · Endocrinologia Japonica · doi:10.1507/endocrj1954.38.253 · Cited by 5
Combination therapy in stage C and D prostatic cancer: rationale and five-year clinical experience
Labrie, F., Dupont, A., B�langer, A., Cusan, L., Gigu�re, M., re, Y. L., Lüthy, I. A., B�gin, D., Labrie, C., Simard, J., et al. (1987) · Cancer and Metastasis Reviews · doi:10.1007/bf00047470 · Cited by 5
L’inactivation des androgènes par les UDP-glucuronosyl-transférases
Bélanger, A. (2003) · médecine/sciences · doi:10.1051/medsci/20031910931 · Cited by 4
Combined androgen blockade and treatment of localized prostate cancer: a real hope when approaching the year 2000
Labrie, F. (1998) · Endocrine Related Cancer · doi:10.1677/erc.0.0050341 · Cited by 4
Combination Therapy with Flutamide: The Therapy of Choice from Early to Advanced Stages of Prostate Cancer
Labrie, F., Dupont, A., Cusan, L., Gomez, J., Suburu, R. E., & Diamond, P. (1996) · Springer eBooks · doi:10.1007/978-3-642-45745-6_6 · Cited by 3
Prostate cancer
Lee, W. R., Giantonio, B. J., & Hanks, G. E. (1994) · Current Problems in Cancer · doi:10.1016/0147-0272(94)90005-1 · Cited by 2
Rôle des UDP-glucuronosyltransférases (UGT) dans le métabolisme des hormones stéroïdiennes.
Lévesque, É., Hum, D., & Bèlanger, A. (2001) · médecine/sciences · doi:10.4267/10608/1785 · Cited by 1
Combination Therapy with Flutamide and Castration (Orchiectomy or LH-RH Agonist) in Untreated Patients with Advanced Prostate Cancer
Dupont, A., Labrie, F., Cusan, L., Gomez, J.-L., Tremblay, M., Lacourcière, Y., Emond, J., & Monfette, G. (1992) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-88-470-2186-0_5 · Cited by 1
Synthèse périphérique des androgènes chez l'homme. Génétique moléculaire du système et sa prise en compte dans le traitement du cancer de la prostate.
Labrie, F., Belanger, A., Dupont, A., Pelletier, G., Luuthe, V., Simard, J., Cusan, L., Labrie, C., Lachance, Y., & Poulin, R. (1990) · médecine/sciences · doi:10.4267/10608/4127 · Cited by 1

Authors: BÉLANGER, A., BROCHU, M., & CLICHE, J.
Affiliations: Université Laval (CA)
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 1986-05
Volume: 62
Issue: 5
Pages: 812-815
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem-62-5-812
OpenAlex: W2071199069
Cited by: 108
References: 20
Citations by year: 2023: 1 · 2019: 1 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2 · 2012: 2
FWCI: 9.54
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords: steroid glucuronides, prostate cancer, castration, androgen metabolism, dehydroepiandrosterone, androstanediol glucuronide, androstanediol, testosterone, dihydrotestosterone, plasma steroid levels
MeSH terms: Aged, Androgens, Androsterone, Dehydroepiandrosterone, Glucuronates, Humans, Male, Middle Aged, Orchiectomy, Prostatic Neoplasms, Dihydrotestosterone, Testosterone, Androstane-3,17-diol, Androstenediol

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks